Cargando…

PB2552: VAYHIA: A RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL TO ASSESS THE EFFICACY AND SAFETY OF IANALUMAB VS PLACEBO IN PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA THAT FAILED ≥1 LINE OF TREATMENT

Detalles Bibliográficos
Autores principales:	Barcellini, Wilma, Michel, Marc, Cuker, Adam, Cooper, Nichola, Ghanima, Waleed, Wong, Raymond, Zaja, Francesco, Zhang, Fengkui, Bezlyak, Vladimir, Nguyen, Thu Thuy, Al-Samkari, Hanny
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Publication Only
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428764/ http://dx.doi.org/10.1097/01.HS9.0000976904.28542.f2

Ejemplares similares

PB2625: VAYHIT2: A RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL OF IANALUMAB VS PLACEBO IN ADDITION TO ELTROMBOPAG IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) WHO FAILED FIRST-LINE STEROID TREATMENT
por: Zaja, Francesco, et al.
Publicado: (2023)

PB2636: VAYHIT1: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL OF IANALUMAB VERSUS PLACEBO IN ADDITION TO FIRST-LINE CORTICOSTEROIDS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP)
por: Cooper, Nichola, et al.
Publicado: (2023)

PB2546: DIAGNOSTIC POWER OF ERYTHROCYTE AND RETICULOCYTE AUTOMATIC PARAMETERS IN THE SCREENING FOR CONGENITAL HEMOLYTIC ANEMIAS
por: Bianchi, Paola, et al.
Publicado: (2023)

PB2241: CHARACTERISTICS AND OUTCOME OF WARM AUTOIMMUNE HEMOLYTIC ANEMIA (WAIHA) IN ADULTS: A RETROSPECTIVE ANALYSIS OF 110 TUNISIAN PATIENTS
por: Bouslama, E., et al.
Publicado: (2022)

New Insights in the Pathogenesis of Autoimmune Hemolytic Anemia
por: Barcellini, Wilma
Publicado: (2015)

The Changing Landscape of Autoimmune Hemolytic Anemia
por: Barcellini, Wilma, et al.
Publicado: (2020)

Diagnosis and Management of Autoimmune Hemolytic Anemias
por: Barcellini, Wilma, et al.
Publicado: (2022)

Mitapivat, a novel pyruvate kinase activator, for the treatment of hereditary hemolytic anemias
por: Al-Samkari, Hanny, et al.
Publicado: (2021)

Bortezomib in autoimmune hemolytic anemia and beyond
por: Pasquale, Raffaella, et al.
Publicado: (2021)

Infectious Complications in Autoimmune Hemolytic Anemia
por: Giannotta, Juri Alessandro, et al.
Publicado: (2021)

PB2608: THE MANAGEMENT OF IMMUNE THROMBOCYTOPENIA (ITP) IN NORWAY IN THE REAL LIFE – ANALYSIS OF THE NOR-ITP REGISTRY
por: Ilicheva, Ekaterina, et al.
Publicado: (2023)

PB2602: POPULATION-BASED STUDY OF HEMOLYTIC UREMIC SYNDROME HOSPITALIZATIONS.
por: Jhaveri, Khushali, et al.
Publicado: (2023)

The choice of new treatments in autoimmune hemolytic anemia: how to pick from the basket?
por: Berentsen, Sigbjørn, et al.
Publicado: (2023)

PB2242: MANAGEMENT OF AUTOIMMUNE HEMOLYTIC ANEMIA.RETROSPECTIVE STUDY OF A SINGLE CENTER
por: Hortensia-Marioara, I., et al.
Publicado: (2022)

PB1990: GLYCOLYTIC ACTIVITY AND EFFECT OF EX-VIVO TREATMENT WITH THE PYRUVATE KINASE (PK) ACTIVATOR AG-946 IN RED BLOOD CELLS FROM LOW-RISK MYELODYSPLASTIC SYNDROMES PATIENTS: A PROOF-OF-CONCEPT STUDY
por: Fattizzo, Bruno, et al.
Publicado: (2023)

PB2345: ADAPTING PATIENT EDUCATIONAL APPROACHES IN PYRUVATE KINASE DEFICIENCY: EUROPE AND NORTH AMERICA FINDINGS FROM THE AAC PATIENT AND CAREGIVER SURVEY
por: Barcellini, W., et al.
Publicado: (2022)

New Insights in Autoimmune Hemolytic Anemia: From Pathogenesis to Therapy
por: Barcellini, Wilma, et al.
Publicado: (2020)

PB2557: CHARACTERISTICS OF AUTOIMMUNE HEMOLYTIC ANEMIA IN ADULTS: A CASE SERIES OF 35 PATIENTS
por: Hanani, Hind, et al.
Publicado: (2023)

2552. Using a Digital Escape Room as a Framework for Deliberate Practice of ID Fundamentals
por: Jeffres, Meghan N
Publicado: (2019)

Confounding factors in the diagnosis and clinical course of rare congenital hemolytic anemias
por: Fattizzo, Bruno, et al.
Publicado: (2021)

Cytokine polymorphisms in patients with autoimmune hemolytic anemia
por: Zaninoni, Anna, et al.
Publicado: (2023)

Editorial: Inflammatory Mechanisms of Hemolytic Diseases
por: Sesti-Costa, Renata, et al.
Publicado: (2022)

Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectives
por: Barcellini, Wilma, et al.
Publicado: (2019)

COVID-19 Associated Atypical Hemolytic Uremic Syndrome
por: Shan Ul Abedin, Muhammad, et al.
Publicado: (2022)

Difficult Cases of Autoimmune Hemolytic Anemia: A Challenge for the Internal Medicine Specialist
por: Fattizzo, Bruno, et al.
Publicado: (2020)

Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia
por: Barcellini, W., et al.
Publicado: (2015)

Congenital Hemolytic Anemias: Is There a Role for the Immune System?
por: Zaninoni, Anna, et al.
Publicado: (2020)

Efficacy of recombinant erythropoietin in autoimmune hemolytic anemia: a multicenter international study
por: Fattizzo, Bruno, et al.
Publicado: (2020)

P1482: RECOMBINANT ERYTHROPOIETIN IN AUTOIMMUNE HEMOLYTIC ANEMIA WITH INADEQUATE RETICULOCYTOSIS: A SINGLE CENTER PROSPECTIVE STUDY
por: Luca Pedone, Giacinto, et al.
Publicado: (2023)

PB2561: DEVELOPMENT OF COLD AGGLUTININ AUTOIMMUNE HEMOLYTIC ANEMIA DURING TREATMENT FOR PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA: A CASE REPORT.
por: Haddad, Nabila, et al.
Publicado: (2023)

Intravascular hemolysis and multitreatment predict thrombosis in patients with autoimmune hemolytic anemia
por: Fattizzo, Bruno, et al.
Publicado: (2022)

Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature
por: Fattizzo, Bruno, et al.
Publicado: (2021)

PB2248: CONCOMITANT HEREDITARY SPHEROCYTOSIS AND PYRUVATE KINASE DEFICIENCY IN A SPANISH FAMILY WITH CHRONIC HEMOLYTIC ANEMIA. CONTRIBUTION OF LASER EKTACYTOMETRY TO CLINICAL DIAGNOSIS
por: Vives Corrons, J.-L., et al.
Publicado: (2022)

PB1935: MANAGEMENT OF NON-SEVERE APLASTIC ANEMIA: LABORATORY WORKUP AND TREATMENT PATTERNS.
por: Cassanello, G., et al.
Publicado: (2022)

PB2300: COMPLEMENT ACTIVATION NEGATIVELY AFFECTS THE PLATELET RESPONSE TO THROMBOPOIETIN RECEPTOR AGONISTS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: A PROSPECTIVE COHORT STUDY
por: Åkesson, A., et al.
Publicado: (2022)

Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US study
por: Al‐Samkari, Hanny, et al.
Publicado: (2022)

PB2550: EXPLORATION OF B-CELL RECEPTOR AND T-CELL RECEPTOR REPERTOIRES REVEALS DISTINCT MECHANISMS IN PURE RED CELL APLASIA, AUTOIMMUNE HEMOLYTIC ANEMIA AND APLASTIC ANEMIA
por: Zhang, Ruoxi, et al.
Publicado: (2023)

Immunotherapy Treatments of Warm Autoimmune Hemolytic Anemia
por: Liu, Bainan, et al.
Publicado: (2013)

Educational Case: Warm Autoimmune Hemolytic Anemia
por: Arays, Ruta, et al.
Publicado: (2020)

Iron overload in patients with rare hereditary hemolytic anemia: Evidence‐based suggestion on whom and how to screen
por: van Straaten, Stephanie, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pud22i07vcodgiu7iq945b2o2t